The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Netupitant-Palonosetron FDC Market Research Report 2025
Synopsis
The netupitant-palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors. Netupitant in the central nervous system inhibits the binding of endogenous tachykinin neuropeptide substance, which prevents chemotherapy-induced nausea and vomiting (CINV).
The global Netupitant-Palonosetron FDC market was valued at US$ 296760 million in 2023 and is anticipated to reach US$ 546270 million by 2030, witnessing a CAGR of 8.6% during the forecast period 2024-2030.
Presently, patient pool segment has witnessed large-scale adoption of netupitant-palonosetron FDC drugs due to rise in number of patient undergoing chemotherapy.
This report aims to provide a comprehensive presentation of the global market for Netupitant-Palonosetron FDC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Netupitant-Palonosetron FDC.
Report Scope
The Netupitant-Palonosetron FDC market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Netupitant-Palonosetron FDC market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Netupitant-Palonosetron FDC manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai Pharmaceutical
Helsinn
Heron Therapeutics
Tesaro
Acacia Pharma
Segment by Type
Flakes
Capsules
Other
Segment by Application
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Netupitant-Palonosetron FDC manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Netupitant-Palonosetron FDC in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The netupitant-palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors. Netupitant in the central nervous system inhibits the binding of endogenous tachykinin neuropeptide substance, which prevents chemotherapy-induced nausea and vomiting (CINV).
The global Netupitant-Palonosetron FDC market was valued at US$ 296760 million in 2023 and is anticipated to reach US$ 546270 million by 2030, witnessing a CAGR of 8.6% during the forecast period 2024-2030.
Presently, patient pool segment has witnessed large-scale adoption of netupitant-palonosetron FDC drugs due to rise in number of patient undergoing chemotherapy.
This report aims to provide a comprehensive presentation of the global market for Netupitant-Palonosetron FDC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Netupitant-Palonosetron FDC.
Report Scope
The Netupitant-Palonosetron FDC market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Netupitant-Palonosetron FDC market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Netupitant-Palonosetron FDC manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai Pharmaceutical
Helsinn
Heron Therapeutics
Tesaro
Acacia Pharma
Segment by Type
Flakes
Capsules
Other
Segment by Application
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Netupitant-Palonosetron FDC manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Netupitant-Palonosetron FDC in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Netupitant-Palonosetron FDC Market Overview
1.1 Product Overview and Scope of Netupitant-Palonosetron FDC
1.2 Netupitant-Palonosetron FDC Segment by Type
1.2.1 Global Netupitant-Palonosetron FDC Market Value Comparison by Type (2024-2030)
1.2.2 Flakes
1.2.3 Capsules
1.2.4 Other
1.3 Netupitant-Palonosetron FDC Segment by Application
1.3.1 Global Netupitant-Palonosetron FDC Market Value by Application: (2024-2030)
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.4 Global Netupitant-Palonosetron FDC Market Size Estimates and Forecasts
1.4.1 Global Netupitant-Palonosetron FDC Revenue 2019-2030
1.4.2 Global Netupitant-Palonosetron FDC Sales 2019-2030
1.4.3 Global Netupitant-Palonosetron FDC Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Netupitant-Palonosetron FDC Market Competition by Manufacturers
2.1 Global Netupitant-Palonosetron FDC Sales Market Share by Manufacturers (2019-2024)
2.2 Global Netupitant-Palonosetron FDC Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Netupitant-Palonosetron FDC Average Price by Manufacturers (2019-2024)
2.4 Global Netupitant-Palonosetron FDC Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Netupitant-Palonosetron FDC, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Netupitant-Palonosetron FDC, Product Type & Application
2.7 Netupitant-Palonosetron FDC Market Competitive Situation and Trends
2.7.1 Netupitant-Palonosetron FDC Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Netupitant-Palonosetron FDC Players Market Share by Revenue
2.7.3 Global Netupitant-Palonosetron FDC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Netupitant-Palonosetron FDC Retrospective Market Scenario by Region
3.1 Global Netupitant-Palonosetron FDC Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Netupitant-Palonosetron FDC Global Netupitant-Palonosetron FDC Sales by Region: 2019-2030
3.2.1 Global Netupitant-Palonosetron FDC Sales by Region: 2019-2024
3.2.2 Global Netupitant-Palonosetron FDC Sales by Region: 2025-2030
3.3 Global Netupitant-Palonosetron FDC Global Netupitant-Palonosetron FDC Revenue by Region: 2019-2030
3.3.1 Global Netupitant-Palonosetron FDC Revenue by Region: 2019-2024
3.3.2 Global Netupitant-Palonosetron FDC Revenue by Region: 2025-2030
3.4 North America Netupitant-Palonosetron FDC Market Facts & Figures by Country
3.4.1 North America Netupitant-Palonosetron FDC Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Netupitant-Palonosetron FDC Sales by Country (2019-2030)
3.4.3 North America Netupitant-Palonosetron FDC Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Netupitant-Palonosetron FDC Market Facts & Figures by Country
3.5.1 Europe Netupitant-Palonosetron FDC Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Netupitant-Palonosetron FDC Sales by Country (2019-2030)
3.5.3 Europe Netupitant-Palonosetron FDC Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Netupitant-Palonosetron FDC Market Facts & Figures by Country
3.6.1 Asia Pacific Netupitant-Palonosetron FDC Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Netupitant-Palonosetron FDC Sales by Country (2019-2030)
3.6.3 Asia Pacific Netupitant-Palonosetron FDC Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Netupitant-Palonosetron FDC Market Facts & Figures by Country
3.7.1 Latin America Netupitant-Palonosetron FDC Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Netupitant-Palonosetron FDC Sales by Country (2019-2030)
3.7.3 Latin America Netupitant-Palonosetron FDC Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Netupitant-Palonosetron FDC Market Facts & Figures by Country
3.8.1 Middle East and Africa Netupitant-Palonosetron FDC Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Netupitant-Palonosetron FDC Sales by Country (2019-2030)
3.8.3 Middle East and Africa Netupitant-Palonosetron FDC Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Netupitant-Palonosetron FDC Sales by Type (2019-2030)
4.1.1 Global Netupitant-Palonosetron FDC Sales by Type (2019-2024)
4.1.2 Global Netupitant-Palonosetron FDC Sales by Type (2025-2030)
4.1.3 Global Netupitant-Palonosetron FDC Sales Market Share by Type (2019-2030)
4.2 Global Netupitant-Palonosetron FDC Revenue by Type (2019-2030)
4.2.1 Global Netupitant-Palonosetron FDC Revenue by Type (2019-2024)
4.2.2 Global Netupitant-Palonosetron FDC Revenue by Type (2025-2030)
4.2.3 Global Netupitant-Palonosetron FDC Revenue Market Share by Type (2019-2030)
4.3 Global Netupitant-Palonosetron FDC Price by Type (2019-2030)
5 Segment by Application
5.1 Global Netupitant-Palonosetron FDC Sales by Application (2019-2030)
5.1.1 Global Netupitant-Palonosetron FDC Sales by Application (2019-2024)
5.1.2 Global Netupitant-Palonosetron FDC Sales by Application (2025-2030)
5.1.3 Global Netupitant-Palonosetron FDC Sales Market Share by Application (2019-2030)
5.2 Global Netupitant-Palonosetron FDC Revenue by Application (2019-2030)
5.2.1 Global Netupitant-Palonosetron FDC Revenue by Application (2019-2024)
5.2.2 Global Netupitant-Palonosetron FDC Revenue by Application (2025-2030)
5.2.3 Global Netupitant-Palonosetron FDC Revenue Market Share by Application (2019-2030)
5.3 Global Netupitant-Palonosetron FDC Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eisai Pharmaceutical
6.1.1 Eisai Pharmaceutical Corporation Information
6.1.2 Eisai Pharmaceutical Description and Business Overview
6.1.3 Eisai Pharmaceutical Netupitant-Palonosetron FDC Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eisai Pharmaceutical Netupitant-Palonosetron FDC Product Portfolio
6.1.5 Eisai Pharmaceutical Recent Developments/Updates
6.2 Helsinn
6.2.1 Helsinn Corporation Information
6.2.2 Helsinn Description and Business Overview
6.2.3 Helsinn Netupitant-Palonosetron FDC Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Helsinn Netupitant-Palonosetron FDC Product Portfolio
6.2.5 Helsinn Recent Developments/Updates
6.3 Heron Therapeutics
6.3.1 Heron Therapeutics Corporation Information
6.3.2 Heron Therapeutics Description and Business Overview
6.3.3 Heron Therapeutics Netupitant-Palonosetron FDC Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Heron Therapeutics Netupitant-Palonosetron FDC Product Portfolio
6.3.5 Heron Therapeutics Recent Developments/Updates
6.4 Tesaro
6.4.1 Tesaro Corporation Information
6.4.2 Tesaro Description and Business Overview
6.4.3 Tesaro Netupitant-Palonosetron FDC Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tesaro Netupitant-Palonosetron FDC Product Portfolio
6.4.5 Tesaro Recent Developments/Updates
6.5 Acacia Pharma
6.5.1 Acacia Pharma Corporation Information
6.5.2 Acacia Pharma Description and Business Overview
6.5.3 Acacia Pharma Netupitant-Palonosetron FDC Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Acacia Pharma Netupitant-Palonosetron FDC Product Portfolio
6.5.5 Acacia Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Netupitant-Palonosetron FDC Industry Chain Analysis
7.2 Netupitant-Palonosetron FDC Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Netupitant-Palonosetron FDC Production Mode & Process
7.4 Netupitant-Palonosetron FDC Sales and Marketing
7.4.1 Netupitant-Palonosetron FDC Sales Channels
7.4.2 Netupitant-Palonosetron FDC Distributors
7.5 Netupitant-Palonosetron FDC Customers
8 Netupitant-Palonosetron FDC Market Dynamics
8.1 Netupitant-Palonosetron FDC Industry Trends
8.2 Netupitant-Palonosetron FDC Market Drivers
8.3 Netupitant-Palonosetron FDC Market Challenges
8.4 Netupitant-Palonosetron FDC Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
